HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma. Issue 1 (19th September 2018)

• Record Type: Journal Article
• Authors: Zhou, Zi‐Qi; Zhao, Jing‐Jing; Chen, Chang‐Long; Liu, Yuan; Zeng, Jian‐Xiong; Wu, Zheng‐Rong; Tang, Yan; Zhu, Qian; Weng, De‐Sheng; Xia, Jian‐Chuan
• Is Part Of: Molecular carcinogenesis. Volume 58:Issue 1(2019)
• Page Start: 76
• Page End: 87
• Publication Date: 2018-09-19
• Subjects: cell cycle -- cell proliferation -- Hepatocellular carcinoma (HCC) -- HUS1 -- tumor suppressor; Carcinogenesis -- Molecular aspects -- Periodicals; 616.994071
• DOI: 10.1002/mc.22908
• Languages: English
• ISSNs: 0899-1987

Abstract

Abstract : The HUS1 checkpoint clamp component (HUS1), which is a member of an evolutionarily conserved, genotoxin‐activated checkpoint complex (Rad9‐Rad1‐Hus1 [9‐1‐1] complex), is involved in cell cycle arrest and DNA repair in response to DNA damage. We conducted this study to investigate the biological significances of HUS1 expression in hepatocellular carcinoma (HCC) development. The mRNA and protein expression levels of HUS1 were determined using Real‐time PCR and Western blot, respectively. One hundered and twenty four paraffin sections from HCC tissues were analyzed by immunohistochemistry to assess the association between HUS1 expression and clinicopathological characteristics of patients. The Kaplan‐Meier method was performed to calculate the OS and RFS curves. Cell proliferation and colony formation assays, cell migration and invasion assays and cell cycle assays were used to determine the suppressor role of HUS1 in vitro. A mouse model was used to determine the effect of HUS1 on tumorigenesis. The expression of HUS1 was significantly decreased in HCC cell lines and tissues, and low HUS1 expression was associated with poor prognosis of HCC patients. Upregulation of HUS1 expression inhibited the cell proliferation, colony formation, migration, and invasion, as well as arrested cell cycle at G0/G1 in HCC cells in vitro. Moreover, sufficient HUS1 expression inhibited the tumor growth in nude mice. Our study revealed for the first time that HUS1 is a potential tumor suppressor that might produce an antitumor effect in human HCC. Furthermore, HUS1 may serve as a prognostic indicator and could be used for therapeutic application in HCC patients.